Thanks for the feedback from the conf call, which I unfortunately couldn't make.
What I don't get - and haven't for a while - is that they have this amazing CPP tech that can also deal with the endosome, libraries with 93% CPP hits, and so forth. Stuff that no one else in the world has and 'could' lead to some amazing health solutions......BUT....they are not signing any deals. Nothing for ages.
Why not? What are we not being told? Is there a gap in the science we're not being told about whilst they are spruiking it? Are pharma raising the bar because they're just so comfortable they don't need to be competitive or get new drugs into the pipeline? Are management just not able to cut a deal?
Nothing is going to happen here until PYC delivers their Jerry McGuire moment & Show Me The Money
PYC Price at posting:
3.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)